Find your path to David
Chief Medical Officer at Bicara Therapeutics
Intro paths
→
In turn, David can intro founders to Bicara Therapeutics's investors below.
Bicara Therapeutics's investors · 12
Aisling CapitalNew YorkBraidwellStamfordEight Roads VenturesMumbai · $5M – $30M checksF-Prime CapitalCambridge · $3M – $10M checks · since 2023Foresite CapitalWest HollywoodOmega FundsBostonPremji InvestMenlo ParkRA CapitalBostonRed Tree VentureSan DiegoThe Rise FundFort WorthTPGSan Francisco · since 2024Vedanta CapitalNew York
Experience
- Bicara TherapeuticsCMO, Bicara Therapeutics2023 — 2026Cambridge, Massachusetts, United States
- AmgenVP, Late Stage Oncology Development2021 — 2023
- GenentechVP, Late Stage Development, PDO2019 — 2022San Francisco Bay Area
- University of Colorado Anschutz Medical CampusProfessor, Radiation Oncology1998 — 2020Aurora, Colorado, United States
Skills & more
Drug DevelopmentClinical Researchclinical trial development1Thoracic Oncologyhead and neck cancerRadiation OncologyCancer ImmunotherapyClinical DevelopmentStrategic PlanningOncology Clinical Research
From David's professional profile.
Frequently asked questions
- Who is David Raben?
- Chief Medical Officer at Bicara Therapeutics
- Where does David Raben work?
- David Raben is Chief Medical Officer at Bicara Therapeutics.
- Where did David Raben go to school?
- David Raben studied at Duke University (Bachelor of Arts - BA, Pschychology); The Johns Hopkins University School of Medicine (Radiation Oncology Residency Program); Wake Forest University School of Medicine (Doctor of Medicine - MD).
Same school
Also attended Duke University954
Marc AndreessenCo-founder & General Partner at Andreessen HorowitzFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeJeremy LevinePartner at Bessemer Venture PartnersZach PerretCo-founder & CEO of Plaid; co-founder of MischiefJulie YangVice President at InvestcorpAyaan PatelInvestor at Lightbank
+ 948 more
Also attended The Johns Hopkins University School of Medicine82
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersStephen P. ZacharyManaging Partner at Sands Capital VenturesS.K. LeeExecutive Coach at Roble VenturesEric HsuAnalyst, Private Equity at Sofinnova Ventures
+ 76 more
Also attended Wake Forest University School of Medicine16
Paulina HillPartner at Sanofi VenturesDavid AdairCo-Founder and Managing Director at Solas BioVenturesMark G. CurrieVenture Partner at Iaso VenturesSamantha PulliamCEO and Chief Medical Officer at Axena HealthRobert GlanzmanExecutive Officer at CleneVolker KnappertzExecutive Vice President of Research & Development at Noema Pharma
+ 10 more
Shared employers
Also worked at Bicara Therapeutics4
Also worked at Amgen190
Parker ConradCo-founder & CEO of RipplingSeth LieblichInvestment Team at 8VCSean BruichChief Technology Officer at Flare Capital PartnersSteph ScottVice President at Questa CapitalBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersKelli McKeirnanDirector of Administration at Westlake Village BioPartners
+ 184 more
Also worked at Genentech247
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 241 more
Also worked at University of Colorado Anschutz Medical Campus18
Stan LapidusCEO, SynapDX & Founding Pillar at Pillar VCJonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesSteven LindsethGeneral Partner at CU Healthcare Innovation FundKimberly MullerGeneral Partner at CU Healthcare Innovation FundKiah WilliamsAssociate at Frazier Life SciencesAtharva PeshkarFounder at AxionOrbital Space
+ 12 more